R. Matthew Smith M.D. Mercy Urology
|
|
- Mae Cummings
- 5 years ago
- Views:
Transcription
1 R. Matthew Smith M.D. Mercy Urology
2 None Disclosures
3 Goals Update growth of Mercy Urology Clinic Quick Review of Hematuria and PSA Present common urologic complaints seen by the primary care physician BPH OAB / Urge Incontinence
4 Mercy Urology Started seeing patients 9/6/2016 Current complement: Physician: One full time (Me), weekend locum coverage Jerry Murphy 5/2017 Nathalie Francois starting 8/2017 Mid Levels NP Identified, starting in 1-2 weeks
5 What are we seeing Cancer Prostate Bladder Kidney Testicular Voiding Dysfunction: BPH overactive bladder/urgency/urge incontinence incontinence Infection: Chronic UTI Reproduction: Vasectomy Peds: Circumcision, bed wetting, reflux
6 Our number so far... September through January New Patients: 516 (410) Sep: 61 (51) Oct: 125 (77) Nov: 138 (98) Dec: 98 (90) Jan: 94 (94) Procedures: 158 Sep: 2 (2) Oct: 26 (23) Nov: 35 (31) Dec: 39 (39) Jan: 46(46)
7 OR Surgery Total: 158 Sep: 18 Oct: 32 Nov: 53 Dec: 55 Jan: 55 What are we doing Cysto / Stent: 23 Ureteroscopy / laser: 31 Bladder tumor: 15 Davinci : 2 (prostatectomy / nephrectomy)
8 From Idle to Full throttle We are busy Ramp up of clinic faster than expected Booking into April... Struggles Access Adding NP to take acute patients and returns How can you help If you have someone that needs to be seen let me know Inbox, text, call If you have someone that has a non-urgent problem... Consider holding referral for a few months
9 New Ventures Advanced Prostate Cancer clinic In Office evaluation for Sacral Nerve Stimulation Urodynamics program
10 Future Growth Men s health clinic ED Testosterone Metabolic Stone clinic Run by NP? Incontinence Center Pelvic floor rehab PTNS Biofeedback
11
12 Hematuria Review Seeing increased ordering of upper tract imaging prior to urologic evaluation We are performing more same day cystoscopy (at time of hematuria NP visit) Some things to remember: Any (Most?) Gross Hematuria gets workup For microhematuria: MUST have a micro. MUST have 3 or more RBC per HPF Dip doesn t count. Importance of getting micro at time of dip UA order dip with reflex to micro
13
14 Prostate Cancer The importance of the DRE/PSA Case Studies.... RG: 65M, otherwise healthy, micro hematuria. PSA 0.9 Distinct small nodule on PSA... Gleason 9 cancer EB: 81M, prostatectomy PSA negligible x 10 years Referral for GH. DRE: HARD right rectal mass. Workup: PSA 15, right hydro, large R pelvic mass 4+4=8 recurrent prostate cancer DH: 68M, Initial screening PSA 1300, DRE: Bilateral nodules Extensive metastatic disease JM: 81M for voiding trial. DRE: extensive nodules PSA: 70, Extensive local disease.
15
16 Voiding Physiology The bladder has 2 functions Filling (Storage) Emptying
17 Voiding Physiology Filling phase Absence of involuntary contractions Accommodation Compliance viscoelastic properties of the bladder Neurogenic bladder: poor compliance high pressures dangerous! Sympathetic stimulation relaxes bladder Parasympathetic inhibition relaxes bladder Closed bladder outlet Sympathetic stimulation
18
19 Voiding physiology Normal Emptying Absence of obstruction (BPH, stricture, etc) Open bladder outlet SNS inhibition decreases involuntary sphincter tone Onuf s nucleus (somatic) inhibition decreases voluntary tone Coordinated detrusor contraction PNS STIMULATION SNS INHIBITION
20
21 Voiding Pnemonic Sympathetic nervous system promotes Storage Parasympathetic nervous system promotes Peeing
22
23 BPH
24 BPH Occurs in the transition zone As men age, Increase in prostate stroma tissue Growth into the lumen obstruction of flow Growth mediated by 5-alpha-reductase Increase in # of alpha-1 receptors Increase in smooth muscle tone
25 BPH
26 Lower Urinary tract symptoms Obstructive Symptoms Decreased force of stream, hesitancy, intermittancy, post void dribbling Irritative symptoms Urgency, Frequency, Nocturia Bladder outlet obstruction from BPH Increased smooth muscle tone Prostate growth into lumen of prostate Degree of obstruction does not correlate with severity of symptoms Definitive test for BOO is urodynamics
27
28 Trabeculations
29 Cellules
30 Divertiucla
31
32 Evaluation and Tx of BPH History and Physical **** Includes DRE Assess severity and bother Formal or Informal (IPSS) Frequency / Volume chart Post Void Residual (EUA not AUA guideline) PSA (Diagnostic, not screening) UA (Diagnostic, not screening)
33 Evaluation and Tx of BPH History and Physical **** Includes DRE Assess severity and bother Formal or Informal (IPSS) Frequency / Volume chart Post Void Residual (EUA not AUA guideline) PSA (Diagnostic, not screening) UA (Diagnostic, not screening)
34 BPH Danger signs Early Urologic Referral Recurrent / Persistent urinary retention Recurrent UTI Recurrent / Persistent gross hematuria Recurrent / large bladder stones Hydronephrosis or renal insufficiency
35 Evaluation and Tx of BPH If no danger signs, assess bother No bother Surveillance Bother Non invasive Tx or meds Obtain voiding diary Polyuria polyuria eval Persistent / worsening disease Advanced eval with urology
36 Assessing for BOO PVR Measurement Scanner or catheter Uroflow Max, average flow; flow time; flow curve Cystoscopy Trabeculations / cellules / Diverticula Urodynamics low flow with high detrusor pressure
37
38
39 Non Invasive Treatment Alter Non BPH factors Avoid substances that promote retention Alpha agonists (pseudophed) Anticholinergic or B3 agonist.... But we often use them for LUTS management Caffeine, spicy food, alcohol may decrease OAB symptoms Nocturia Decreased fluid intake Avoid night time diuretics Surveillance Repeat evaluation every year
40 Phytotherapy Not recommended by AUA Efficacy data are lacking? Some men may benefit Commonly used substances Saw Palmetto (Serenoa repens) African Plum Stinging nettle Pumpkin seed African Star grass Rye grass pollen
41 Alpha blockers Inhibit alpha-1 adrenergic receptors, relaxing smooth muscles in prostate and bladder neck Prostate has alpha-1-a receptor Alpha-1-B in blood vessels Alpha-1-D in nasal passages congestion Non-selective alpha blockers Terazosin (Hytrin), doxazosin (cardura), alfuzosin(uroxatal) Selective Alpha blockers Tamsulosin (flomax), sildosin (Rapaflo)
42 Flow effects Effects Usually occurs within 8 hours for alpha-1-a selective 2-4 weeks for non selective Symptom effects Begin in 1-3 days, may take several months to reach maximum effect Side Effects Dizziness, fatigue, nasal congestion, orthostatic hypotension (uncommon), syncope (rare) Retrograde ejaculation (28% sildosin, 18% tamsulosin)
43 Intraoperative Floppy Iris Syndrome Any prior use of alpha blockers put a patient at risk of intraoperative floppy iris syndrome during cataract surgery Ophthalmology needs to know prior to procedure
44 5-alpha-reductase inhibitors Finasteride (proscar), and Dutasteride(Avodart) Blocks conversion of Testosterone to Di-Hydro- Testosterone Reduces prostate volume by 20-25% Increases flow by 10% Improves symptom score by 25% Decreases episodes of acute retention by 50% Decreases PSA by 50% (9-12 months) Decreases chronic hematuria from prostate
45 5-alpha-reductase inhibitors Finasteride (proscar), and Dutasteride(Avodart) Blocks conversion of Testosterone to Di-Hydro- Testosterone Reduces prostate volume by 20-25% Increases flow by 10% Improves symptom score by 25% Decreases episodes of acute retention by 50% Decreases PSA by 50% (9-12 months) Decreases chronic hematuria from prostate
46 5AR Side Effects Impotence (<5%) Decreased libido (<4%) Decreased volume of ejaculate (<3%) Gynecomastia (<1%) Does finasteride increase risk of high grade prostate cancer? Probably not Increase in incidence likely due to increased yield.
47
48 Tadalifil Used for Erectile dysfunction and BPH Improves max flow rate Comparable to tamsulosin for decreasing symptoms from BPH Other PDE-5 not approved (short half life; prn dosing) Tadalafil is long half life, can be given daily
49 Combination Tx MTOPS / CombAT trials Alpha blocker and finasteride/dutasteride Combination therapy is better than either agent alone Progression of BPH Monotherapy ~ 60% Dual thearpy ~ 35% Prevention of acute retention Monotherapy (5ARI) 68% Dual therapy 81% Reduction in need for surgery Monotherapy (5ARI) 64% Dual therapy 67%
50 BPH and Overactive Bladder BOO from BPH may cause over-activity Secondary effect on bladder OAB may occur in absence of BOO See next section No OAB meds are approved for BPH I use them in men with Primarily irritative symptoms and low PVR
51
52 OAB / Urge Incontinence OAB clinical diagnosis urinary urgency, usually accompanied by frequency and nocturia, with or without urge incontinence, in the absence of a urinary tract infection or other obvious pathology Risk factors Age Chronic obstruction (BPH) Pregnancy Vaginal delivery Postmenopausal status CNS disorders (stroke, SCI, etc) Most common cause: idiopathic
53 Complicated Stratifying OAB Severe symptoms Young age Gross Hematuria Recurrent UTI Significant Pelvic Organ Prolapse Fecal Incontinence Constipation Hx of pelvic cancer, pelvic/vaginal surgery, radiation Neurologic disease Impaired mobility Poorly controlled DM Uncomplicated None of the above
54 Workup/Tx for uncomplicated OAB Workup History / Physical, Urinalysis Assess bother Behavioral Therapy Timed voiding (q2hrs while awake) Fluid Management Avoid bladder irritants (caffeine, spicy foods, etc) Avoid constipation Weight loss Smoking Cessation Pelvic floor therapy (Kegals) Hold 6-8 secs, relax. X10, TID Oral Meds
55 Oral Meds - anticholinergics Inhibit muscarinic receptors, which reduce detrusor overacitivty All anticholinergics have similar efficacy Improved efficacy if combined with Pelvic floor muscle therapy Initial Improvement in 1 week, may take up to 3 months Contraindications: Urinary retention Gastric retention concurrent K theraphy Intestinal obstruction Uncontrolled narrow angle glaucoma Myasthenia Gravis
56 Oral Meds - Anticholinergics Side Effects Dry mouth Constipation Blurry vision Headache Dizziness Drowsiness Rare: Tachycardia, Urinary retention, Cognitive impairment, impaired perspiration
57 Anticholinergic Meds Oxybutynin (Ditropan) Short acting / long acting. Highest rate of dry mouth/ constipation / cognitive impairment Tolteridine (Detrol) Darifenacin (Enablex) Solifenacin (Vesicare) Fesoteridine (Toviaz) Trospium (Sanctura) least effect on CNS (quaternary amine)
58 How do I pick an anti-cholinergic? Side Effects Try not to use Immediate release oxybutynin Sanctura for elderly Cost Whatever their insurance will pay for Don t let them touch it
59 B3 agonist - Mirabegron Actively relaxes detrusor muscle Bladder contains all 3 Beta receptors B3 most abundant B1 increase HR, BP (kidney renin; vascular contraction) Mirabegron has low affinity for B1/B2 Start to see effects at 4 weeks, may take 8-12 for full effect SE: Increased BP (10% - don t give in uncontrolled HTN, monitor), Headache (3-4%), Nasopharyngitis (3-4%), Tachycardia (rare), Retention (rare)
60
61 Refractory/Complicated OAB Further workup PVR Voiding Diary Cytology Renal U/S Cystoscopy Urodynamics
62 Surgical Tx of OAB Botox Onabutulinumtoxin-A (OBTA) Inhibits release of acetylcholine from vesicles in the presynaptic side of the neuromuscular junction. Efficacy 60-75% of pts see improvement of 50% or more 30-40% see complete resolution Duration: 3-12 months SE: UTI Urinary retention (must be willing to self cath) Systemic spread is rare
63 Percutaneous Tibial Nerve Stimulation Percutaneous needle electrode stimulates Tibial Nerve (S3 root) Leads to modification of voiding reflex Treatment course 30 min weekly x 12 weeks Customized maintenance schedule Efficacy: Significant improvement in 60% of patients. Contraindications: Pasemaker/Defibrillator, coagulopathy, pregnancy
64
65 Sacral Nerve Stimulation (Interstim) Modifies voiding reflex by stimulating S3 afferent nerve 2 stage process In office or OR test If test shows improvement, implantation of permanent generator Indications: Failure of conservative Tx for OAB, Urge Urinary Incontinence, urgency, frequency, Nonobstructive urinary retention. Efficacy: 50% dry 60-90% improved
66
67 Interstim Contraindications Need for MRI Previous damage to sacral nerves
68 Hematuria Get a microscopic urine Prostate Cancer Review DRE, strongly consider PSA BPH Alpha blockers/5ari are mainstays of treatment Look for danger signs OAB Uncomplicated/mildly complicated treat with anti-cholinergics / mirabegron Complicated or refractory: Urology referral
69 Future Topics -??? Erectile Dysfunction Bladder Pain Syndrome / Interstitial Cystitis Premature Ejaculation... You tell me....
70 Thank You
Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine
Victoria Sharp, MD, MBA, FAAFP Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Market Chief Medial Officer AmeriHealth Caritas Family of Companies Office phone: (515) 330-3740
More informationMANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH
MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size
More informationURGE MOTOR INCONTINENCE
URGE MOTOR INCONTINENCE URGE INCONTINENCE COMMONEST TYPE IN ELDERLY WOMEN Causes: 1 - Defects in CNS regulation Stroke Parkinson s disease Dementia (Alzheimer s and other types) Normopressure hydrocephalus
More informationOveractive Bladder Syndrome
Overactive Bladder Syndrome behavioural modifications to pharmacological and surgical treatments Dr Jos Jayarajan Urologist Austin Health, Eastern Health Warringal Private, Northpark Private, Epworth Overactive
More informationLower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist
Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,
More informationProstate Disease. Chad Baxter, MD
Prostate Disease Chad Baxter, MD Managing BPH and LUTS Chad Baxter, MD Department of Urology cbaxter@mednet.ucla.edu 33 nd Annual UCLA Intensive Course in Geriatric Medicine & Board Review Prevalence of
More informationVoiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU.
Voiding Dysfunction 2009 Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Objectives Understand and explain physiologic function and dysfunction of lower urinary tract.
More informationBenign Prostatic Hyperplasia (BPH):
Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate
More informationLower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital
Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of
More informationManagement of OAB. Lynsey McHugh. Consultant Urological Surgeon. Lancashire Teaching Hospitals
Management of OAB Lynsey McHugh Consultant Urological Surgeon Lancashire Teaching Hospitals Summary Physiology Epidemiology Definitions NICE guidelines Evaluation Conservative management Medical management
More informationBenign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary
Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,
More informationObjectives. Prevalence of Urinary Incontinence URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS
URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS Lisa S Pair, MSN, CRNP Division of Urogynecology and Pelvic Reconstructive Surgery Department of Obstetrics and Gynecology University of Alabama
More informationTHE OVER-ACTIVE BLADDER (OAB)
THE OVER-ACTIVE BLADDER (OAB) Passage of urine is caused by the bladder muscle contracting coordinated with the relaxation of the sphincter muscles, which is controlled by higher centers in the central
More informationUrinary Incontinence for the Primary Care Provider
Urinary Incontinence for the Primary Care Provider Diana J Scott FNP-BC https://youtu.be/gmzaue1ojn4 1 Assessment of Urinary Incontinence Urge Stress Mixed Other overflow, postural, continuous, insensible,
More informationR. Matthew Smith M.D. Stacy Pohlman, ARNP Jessica Gengler, PT, DPT Mercy Urology
R. Matthew Smith M.D. Stacy Pohlman, ARNP Jessica Gengler, PT, DPT Mercy Urology Disclosures Matt Smith None Stacy Pohlman None Jessica Gengler None Topics Clinical Pathway Development Prostate Cancer
More informationUrogynecology in EDS. Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018
Urogynecology in EDS Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018 One in three like me Voiding Issues Frequency/Urgency Urinary Incontinence neurogenic bladder Neurologic supply
More informationBenign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy
Benign Prostatic Hyperplasia Management of Benign Prostatic Hyperplasia Goals of Therapy Improve or abolish lower urinary tract symptoms (LUTS) Prevent or delay clinical progression of benign prostatic
More informationDisclosures. Geriatric Incontinence and Voiding Dysfunction. Agenda. Agenda. UI: a Geriatric Syndrome. Geriatric Syndromes 9/7/2018.
Disclosures Geriatric Incontinence and Voiding Dysfunction None Shachi Tyagi MD, MS Assistant Professor Division of Geriatric Medicine University of Pittsburgh Medical Center UI: a Geriatric Syndrome Geriatric
More informationManagement of LUTS. Simon Woodhams February 2012
Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract
More informationDiagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. TARGET POPULATION Eligibility Decidable (Y or N) Inclusion Criterion non-neurogenic OAB Exclusion Criterion
More informationOveractive bladder (OAB) affects approximately 15% of the adult population. Diagnosis is based
Overactive bladder (OAB) affects approximately 15% of the adult population. Diagnosis is based upon a medical history, and includes a focused physical exam (abdominal, neurological, pelvic in females and
More informationNON-Neurogenic Chronic Urinary Retention AUA White Paper
NON-Neurogenic Chronic Urinary Retention AUA White Paper Great Lakes SUNA Inside Urology March 16, 2018 Michelle J. Lajiness FNP-BC Nurse Practitioner DMC Urology Incidence Really unknown Lack consensus
More informationOveractive Bladder. Jennifer Mosher, WHNP-BC, CUNP Mercy Health Pelvic Medicine and Urogynecology Muskegon, Michigan
Overactive Bladder Jennifer Mosher, WHNP-BC, CUNP Mercy Health Pelvic Medicine and Urogynecology Muskegon, Michigan Speaker Disclosure I have nothing to disclose. 2 Learning Objectives Define OAB Identify
More informationTools for Evaluation. Urodynamics Case Studies. Case 1. Evaluation. Case 1. Bladder Diary SUI 19/01/2018
Urodynamics Case Studies Christopher K. Payne, MD Vista Urology & Pelvic Pain Partners Emeritus Professor of Urology, Stanford University Tools for Evaluation Ears, Eyes, and Brain Bladder diary Stress
More informationThe Neurogenic Bladder
The Neurogenic Bladder Outline Brandon Haynes, MD Resident Physician Department of Urology Jelena Svircev, MD Assistant Professor Department of Rehabilitation Medicine Anatomy and Bladder Physiology Bladder
More informationMr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.
Mr. GIT KAH ANN Pakar Klinikal Urologi Hospital Kuala Lumpur drgitka@yahoo.com 25 Jan 2007 HIGHLIGHTS Introduction ICS Definition Making a Diagnosis Voiding Chart Investigation Urodynamics Ancillary Investigations
More informationLUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital
LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital LUTS- Classification Men LUTS can be divided into: Storage Voiding Frequency Nocturia Urgency
More informationURINARY INCONTINENCE
Center for Continence Care and Pelvic Medicine What is urinary incontinence? URINARY INCONTINENCE Urinary incontinence is the uncontrollable loss of urine. The amount of urine leaked can vary from only
More informationBotulinum Toxin: Applications in Urology
Botulinum Toxin: Applications in Urology Dr. Lee Jonat, PGY-4 Department of Urologic Sciences University of British Columbia Outline Mechanism of Action Technical Considerations Adverse Events Neurogenic
More informationGeriatric Urinary Incontinence
Geriatric Urinary Incontinence Neil M. Resnick, MD Thomas Detre Professor of Medicine Chief, Division of Geriatric Medicine University of Pittsburgh/UPMC UI: The Problem Prevalence in elderly 33% Morbidity
More informationVarious Types. Ralph Boling, DO, FACOG
Various Types Ralph Boling, DO, FACOG The goal of this lecture is to increase assessment and treatment abilities for physicians managing urinary incontinence (UI) patients. 1. Effectively communicate with
More informationLUTS & Cancer pathway. Mr Francis Thomas Urology Consultant DRI &BDGH
LUTS & Cancer pathway Mr Francis Thomas Urology Consultant DRI &BDGH Topics Male and female LUTS Urinary retention Post void Residual urine Referral pathway LUTS Raised PSA Hematuria Services in community
More informationBPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence.
BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG FECSM Beaconsfield Medical Practice, Brighton & Brighton & Sussex Universities NHS Trust As man draws near the common goal Can anything be sadder Than he
More informationPresentation Goals 4/14/2015. Pharmacology for Urinary Incontinence in Women. Medications Review anti muscarinic medications Focus on newer meds
Presentation Goals Pharmacology for Urinary Incontinence in Women Medications Review anti muscarinic medications Focus on newer meds Introduce beta adrenergic medications Current Concepts in Drug Therapy
More informationMale Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon
Male Lower Urinary Tract Symptoms: Management in primary care and beyond Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon 1 LUTS Very common: 1/3 men over age of 50 have moderate to severe LUTS
More informationBladder dysfunction in ALD and AMN
Bladder dysfunction in ALD and AMN Sara Simeoni, MD Department of Uro-Neurology National Hospital for Neurology and Neurosurgery Queen Square, London 10:15 Dr Sara Simeoni- Bladder issues for AMN patients
More informationOveractive Bladder: Diagnosis and Approaches to Treatment
Overactive Bladder: Diagnosis and Approaches to Treatment A Hidden Condition* Many Many patients self-manage by voiding frequently, reducing fluid intake, and wearing pads Nearly Nearly two-thirds thirds
More informationDiagnosis and Mangement of Nocturia in Adults
Diagnosis and Mangement of Nocturia in Adults Christopher Chapple Professor of Urology Sheffield Teaching Hospitals University of Sheffield Sheffield Hallam University UK 23 rd October 2015 Terminology
More informationNEUROGENIC BLADDER. Dr Harriet Grubb Dr Alison Seymour Dr Alexander Joseph
NEUROGENIC BLADDER Dr Harriet Grubb Dr Alison Seymour Dr Alexander Joseph OUTLINE Definition Anatomy and physiology of bladder function Types of neurogenic bladder Assessment and management Complications
More informationOverview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014
Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011
More informationAdvanced Care for Female Overactive Bladder & Urinary Incontinence. Department of Urology Kaiser Permanente Santa Rosa
Advanced Care for Female Overactive Bladder & Urinary Incontinence Department of Urology Kaiser Permanente Santa Rosa Goals Participants will: Review normal urinary tract anatomy and function Understand
More informationCanadian Undergraduate Urology Curriculum (CanUUC): Prostate Diseases
Canadian Undergraduate Urology Curriculum (CanUUC): Prostate Diseases LUTS/Benign Prostate Hyperplasia Objectives 1. List the lower urinary tract symptoms (LUTS) found in men with BPH. 2. List the differential
More informationNeurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder.
Definition: Neurogenic bladder Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder. Types: Nervous system diseases: Congenital: like myelodysplasia like meningocele.
More informationURINARY INCONTINENCE. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
URINARY INCONTINENCE Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara Definition The involuntary loss of urine May denote a symptom, a sign or a condition Symptom the
More informationEvaluation and Treatment of Incontinence
Evaluation and Treatment of Incontinence Classification of Incontinence Failure to empty: Overflow incontinence Failure to store Stress Incontinence Urge Incontinence Physiology of voiding CNS Brain sends
More informationDiagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center
Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition
More informationManagement of LUTS after TURP and MIT
Management of LUTS after TURP and MIT Hong Sup Kim Konkuk University TURP & MIT TURP : Gold standard MIT TUIP TUNA TUMT HIFU LASER Nd:YAG, ILC, HoLRP, KTP LUTS after TURP and MIT Improved : about 70% Persistent
More informationManagement, Evaluation, and Treatment of Overactive Bladder and Urinary Incontinence
Management, Evaluation, and Treatment of Overactive Bladder and Urinary Incontinence Arthur Mourtzinos, MD, MBA Co-Vice Chair, Institute of Urology Director, Continence Center Assistant Professor of Urology,
More informationAs man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5
BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG Beaconsfield Medical Practice, Brighton As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder
More informationDr. Melissa Kagarise, PA C
Dr. Melissa Kagarise, PA C This program has been supported by an educational grant from Pfizer Pharmaceuticals PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of
More informationCase studies: LUTS. Case 1 history. Case 1 - questions. Case 1 - outcome. Case 2 - history. Case 1 learning point 14/07/2015 DR JON REES
Case 1 history Case studies: LUTS DR JON REES A 49 year old male comes to see you he has had gradual deterioration of his flow over the last few years- he saw a colleague of yours 6 weeks ago who recorded
More informationPrimary Care management of Overactive Bladder (OAB)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Primary Care management of Overactive Bladder (OAB) Prescribing Tips All medicines for OAB have similar dose-related efficacy. More than one agent (up
More informationOveractive Bladder. When to see a doctor. Normal bladder function
Overactive Bladder Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary
More informationUrinary Incontinence. Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital
Urinary Incontinence Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital Affects women of all ages Impacts physical, psychological & social wellbeing Impact on families & carers Costs the
More informationOveractive bladder. Information for patients from Urogynaecology
Overactive bladder Information for patients from Urogynaecology An overactive bladder (OAB) is a very common problem. It can cause distressing symptoms that are difficult to control. These can include
More informationEvaluation & Management of Overactive Bladder
Evaluation & Management of Overactive Bladder Disclosures/Conflict of Interest/Bias I have no financial relationship with any of the companies that produce the products I m about to discuss I have no conflicts
More informationTREATMENT OF OVERACTIVE BLADDER IN ADULTS FUGA 2016 KGH
TREATMENT OF OVERACTIVE BLADDER IN ADULTS FUGA 2016 KGH CONTENTS Overactive bladder (OAB) Treatment of OAB Beta-3 adrenoceptor agonist (Betmiga ) - Panacea? LASER treatment - a flash in the pan or the
More informationWhat should we consider before surgery? BPH with bladder dysfunction. Inje University Sanggye Paik Hospital Sung Luck Hee
What should we consider before surgery? BPH with bladder dysfunction Inje University Sanggye Paik Hospital Sung Luck Hee Diagnostic tests in three categories Recommendation: there is evidence to support
More informationIncontinence. When I was given this topic in urology to discuss with you today I
Incontinence When I was given this topic in urology to discuss with you today I was slightly disappointed. I personally see mostly men for problems such as stones, benign prostatic hyperplasia, prostate
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,
More informationDr Jonathan Evans Paediatric Nephrologist
How do I manage a patient with intractable daytime wetting: Dr Jonathan Evans Paediatric Nephrologist Of 107 children aged 11-12 with day-wetting 91 (85%) were dry at 15-16 yr Swithinbank et al BJU 1998
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme Clinical guideline CG97: The management of lower urinary tract symptoms in men Publication date May
More informationBenign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia (BPH) Definition Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate gland enlargement can cause bothersome
More informationManagement of male LUTS in general practice
17 Management of male LUTS in general practice MARK J. SPEAKMAN AND FAITH MCMEEKIN The initial management of lower urinary tract symptoms in men is usually carried out in primary care. The authors explain
More informationMini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano
Dipartimento di Urologia Direttore Prof. Giorgio Guazzoni Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano alberto.saita@humanitas.it
More information10/9/2015. Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University
Dana A. Brown, Pharm.D., BCPS Assistant Dean for Academics, Associate Professor of Pharmacy Practice Palm Beach Atlantic University 1. Explain the pathophysiology of benign prostatic hyperplasia (BPH),
More informationWhat is Benign Prostatic Hyperplasia (BPH)?
What is Benign Prostatic Hyperplasia (BPH)? Benign prostatic hyperplasia (BPH) is an enlarged prostate. The prostate goes through two main growth periods as a man ages. The first occurs early in puberty,
More informationManagement of Female Stress Incontinence
Management of Female Stress Incontinence Dr. Arvind Goyal Associate Professor (Urology& Renal Transplant) Dayanand Medical College & Hospital, Ludhiana, Punjab, India Stress Incontinence Involuntary loss
More informationOveractive bladder can result from one or more of the following causes:
Overactive bladder can affect people of any age; however, it is more common in older people. Effective treatments are available and seeing your doctor for symptoms of overactive bladder often results in
More informationManagement of Voiding Problems in Older Men. Dr. John Fenn Consultant, QEH 10 th October, 2005
Management of Voiding Problems in Older Men Dr. John Fenn Consultant, QEH 10 th October, 2005 Voiding Problems Poor stream Hesitancy Straining Incomplete emptying Intermittent micturition Terminal dribbling
More informationUrinary Incontinence. Lee A. Jennings, MD, MSHS. Assistant Professor Reynolds Department of Geriatrics University of Oklahoma Health Sciences Center
Urinary Incontinence Lee A. Jennings, MD, MSHS Assistant Professor Reynolds Department of Geriatrics University of Oklahoma Health Sciences Center Slides adapted from Alison Moore, MD, MPH University of
More informationDysfunctional voiding
Dysfunctional voiding The importance of assessment, diagnosis and treatment of dysfunctional voiding and its role in recurrent UTI Dr Dean Wallace Consultant Paediatric Nephrologist RMCH Objectives Development
More informationPosterior Tibial Nerve Stimulation
Posterior Tibial Nerve Stimulation Policy Number: Original Effective Date: MM.02.025 01/01/2015 Lines of Business: Current Effective Date: HMO; PPO; QUEST Integration 02/01/2015 Section: Medicine Place(s)
More information03/13/18. A. Symptoms lasting for greater than or equal to 12 months that have resulted to significant impairment in activities of daily living; and
Reference #: MC/I008 Page: 1 of 5 PRODUCT APPLICATION: PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services, Inc. (PAS) Non-ERISA PreferredOne Community Health Plan
More informationPhysiology & Neurophysiology of lower U.T.
Physiology & Neurophysiology of lower U.T. Classification of voiding dysfunction Evaluation of a child with voiding dysfunction Management Storage Ø Adequate volume of urine Ø At LOW pressure Ø With NO
More informationMODULE 3: BENIGN PROSTATIC HYPERTROPHY
MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student
More informationUrinary Continence & Management Post Stroke
Urinary Continence & Management Post Stroke Incontinence and Stroke occurs in greater than 50% of acute stroke patients despite the personal, economic and psychosocial impact treatment evidence specific
More informationSome people experience occasional, minor leaks of urine. Others wet their clothes frequently.
Urinary Incontinence Urinary incontinence the loss of bladder control is a common and often embarrassing problem. The severity ranges from occasionally leaking urine when you cough or sneeze to having
More information김준철 가톨릭대학교의과대학비뇨기과학교실
비뇨기계자율신경병증의치료 김준철 가톨릭대학교의과대학비뇨기과학교실 Introduction Urologic complications have increasingly become a concern in those affected by DM Genitourinary problems are included among these complications, related
More informationBPH OVERVIEW / MANAGEMENT. Richard L Haddad Norwest Private Hospital 17 Oct 2018
BPH OVERVIEW / MANAGEMENT Richard L Haddad Norwest Private Hospital 17 Oct 2018 Introduction Learning outcomes; Develop a management plan for BPH patients Describe the new medical therapies in BPH and
More informationFrank P. Begun, M.D. Associate Professor, Urology
Benign Prostate Disorders Frank P. Begun, M.D. Associate Professor, Urology Medical Director, Urological Services at OSU East Hospital The Ohio State University Objectives/Goals To understand the causes
More informationPelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS
Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS OhioHealth, Columbus Ohio Disclosures I have nothing to disclose Objectives Describe the role of a pelvic floor therapist in
More informationBladder Dysfunction in Multiple Sclerosis. by Nancy J. Holland, EdD, RN and Nancy C. Reitman, MA, RN
Clinical Bulletin Information for Health Professionals Bladder Dysfunction in Multiple Sclerosis by Nancy J. Holland, EdD, RN and Nancy C. Reitman, MA, RN Effective bladder management strategies make it
More informationIncontinence; Lets talk about it. Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery
Incontinence; Lets talk about it Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery Select the most appropriate subtitle for this talk A: Bladders gone wild! B: There s no such thing
More informationWorkshop : Managing Urinary Stones and BPH
Workshop : Managing Urinary Stones and BPH How common are they? lifetime risk 15% men, 6% women Dr John Tuckey Urologist Auckland 105 new stones /100,000 peak age incidence 30-50 males 2.3:1 How common
More informationUBC Department of Urologic Sciences Lecture Series. Voiding Dysfunction & BPH
UBC Department of Urologic Sciences Lecture Series Voiding Dysfunction & BPH Objectives Today 1. Anatomy of the lower urinary tract A) Innervation of the bladder B) Normal voiding 2. Classify Neurogenic
More informationThe Prostate and Its Challenges LUTS in the Aging Male
The Prostate and Its Challenges LUTS in the Aging Male HJ Rayala, MD/PhD Urologic Surgeon, Cambridge Health Alliance Instructor, Harvard Medical School Financial Disclosures Spouse Torque Pharma Employee/Stock
More informationUrinary Adverse Events after Radiation Therapy for Prostate Cancer
Urinary Adverse Events after Radiation Therapy for Prostate Cancer Sexual Medicine Society of North America Scottsdale, Arizona 2016 Jaspreet S. Sandhu, MD Department of Surgery/Urology Memorial Sloan
More informationManagement of Voiding Dysfunction after Prostate Radiotherapy
Management of Voiding Dysfunction after Prostate Radiotherapy Up to Date Symposium on Uro-Oncology December 7, 2012 Belo Horizonte, Brazil Jaspreet S. Sandhu, MD Department of Surgery/Urology Memorial
More informationLUTS after TURP: How come and how to manage? Matthias Oelke
LUTS after TURP: How come and how to manage? Matthias Oelke Department of Urology Global Congress on LUTD, Rome, 26 th June 2015 Disclosures Consultant, speaker, trial participant and/or research grants
More informationUrinary Incontinence. Alison A Moore, MD, FACP
Urinary Incontinence Alison A Moore, MD, FACP Professor of Medicine/Geriatric Medicine David Geffen School of Medicine at UCLA Department of Medicine, Division of Geriatrics Urinary Incontinence (UI) Involuntary
More informationProstate gland disorder พ.ต.ต.นพ.ส ร ต ก ตต ศ ภพร นพ.(สบ.2) โรงพยาบาลต ารวจ ส าน กงานต ารวจแห งชาต
Prostate gland disorder พ.ต.ต.นพ.ส ร ต ก ตต ศ ภพร นพ.(สบ.2) โรงพยาบาลต ารวจ ส าน กงานต ารวจแห งชาต Prostate cancer Overview Diagnosis Treatment Lower urinary tract symptoms EPIDEMIOLOGY The most common
More informationBenign Prostatic Hyperplasia. Shahideh Amini Pharm.D clinical pharmacy resident Tehran university of medical science Department of pharmacotherapy
Benign Prostatic Hyperplasia Shahideh Amini Pharm.D clinical pharmacy resident Tehran university of medical science Department of pharmacotherapy Definition BPH is a common disorder that increases in frequency
More informationINCONTINENCE. Continence and Pelvic Floor Rehabilitation TYPES OF INCONTINENCE STRESS INCONTINENCE STRESS INCONTINENCE STRESS INCONTINENCE 11/08/2015
INCONTINENCE Continence and Pelvic Floor Rehabilitation Dr Irmina Nahon PhD Pelvic Floor Physiotherapist www.nahonpfed.com.au Defined as the accidental and inappropriate passage of urine or faeces (ICI
More informationPaediatric Urotherapy Training
Paediatric Urotherapy Training Frances Shit NS, MSc (Hons), ET, Dept. of Surgery, PWH, CUHK HKSAR Urinary Incontinence in Children Urine leakage in a child from 5 years of age Leakage occurs on a regular
More informationThese drugs produce effects similar to the sympathetic nervous system
Terms adrenergic Drugs mydriasis sympathetic nervous system adrenergic drugs adrenergic mechanism of action positive inotropic effect positive chronotropic effect positive dromotropic effect adrenergic
More informationPolicy for Prostatism/Lower Urinary Tract Symptoms in men
NHS Halton Clinical Commissioning Group NHS Liverpool Clinical Commissioning Group NHS St Helens Clinical Commissioning Group NHS South Sefton Clinical Commissioning Group NHS Southport and Formby Clinical
More informationElements for a Public Summary
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Benign prostatic hyperplasia (BPH), also called benign prostatic hypertrophy or benign prostatic obstruction, is a condition in
More information